Could oritavancin be a promising alternative treatment for staphylococcal bone and joint infections? Insights from the determination of oritavancin minimum inhibitory concentrations in a collection of clinical isolates from the French National reference centre for staphylococci - Berrada, M.; Kolenda, C.; Tristan, A.; Laurent, F.; Dupieux, C. (European Journal of Clinical Microbiology & Infectious Diseases, 2026)